Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Waste Management Inc WM

Waste Management, Inc. is a holding company. The Company is a provider of environmental solutions. The Company, through its subsidiaries, provides collection, recycling and disposal services to millions of residential, commercial, industrial and municipal customers throughout the U.S. and Canada. The Company evaluates its Collection and Disposal businesses primarily through two geographic segments: East Tier and West Tier. Its East Tier primarily consists of geographic areas located in the Eastern U.S., the Great Lakes region and substantially all of Canada. West Tier includes geographic areas located in the Western U.S., including the upper Midwest region, and British Columbia, Canada. It also provides ancillary services. Its Recycling Processing and Sales segment includes the processing and sales of materials collected from residential, commercial and industrial customers. Its WM Renewable Energy segment develops, operates and promotes projects for the beneficial use of landfill gas.


NYSE:WM - Post by User

Post by Maemae4on Jun 03, 2022 5:31am
93 Views
Post# 34728784

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance




FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


<< Previous
Bullboard Posts
Next >>